Citations (234)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (42)
Anna Kerins, Marta Koszyczarek, Caroline Smith, Phil Butler, Rob Riley, Vamsi Madgula, Nilkanth Naik, Matthew R. Redinbo & Ian D. Wilson. (2022) The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652. Xenobiotica 52:8, pages 904-915.
Read now
Read now
Siva Nageswara Rao Gajula, Nimisha Nadimpalli & Rajesh Sonti. (2021) Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metabolism Reviews 53:3, pages 459-477.
Read now
Read now
Kyeong-Ryoon Lee, Jong-Woo Jeong, Hun-Chan Hyun, Eunseo Jang, Sunjoo Ahn, Sungwook Choi, Sang Hoon Joo, Sungsub Kim & Tae-Sung Koo. (2018) Pharmacokinetics of tafamidis, a transthyretin amyloidosis drug, in rats. Xenobiotica 48:8, pages 831-838.
Read now
Read now
Roslyn Thelingwani, Carina Leandersson, Britta Bonn, Peter Smith, Kelly Chibale & Collen Masimirembwa. (2016) Characterisation of artemisinin–chloroquinoline hybrids for potential metabolic liabilities. Xenobiotica 46:3, pages 234-240.
Read now
Read now
Naoki Takahashi & Tohru Izuchi. (2016) Characterisation of liver-specific distribution of a novel 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonist, SKL-13784: comparison with GC-1. Xenobiotica 46:2, pages 108-116.
Read now
Read now
Roslyn Thelingwani, Britta Bonn, Kelly Chibale & Collen Masimirembwa. (2014) Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity. Expert Opinion on Drug Metabolism & Toxicology 10:10, pages 1313-1324.
Read now
Read now
Li Di. (2014) The role of drug metabolizing enzymes in clearance. Expert Opinion on Drug Metabolism & Toxicology 10:3, pages 379-393.
Read now
Read now
John R. Foster, Garry Lund, Svetlana Sapelnikova, D. Lorne Tyrrell & Norman M. Kneteman. (2014) Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies. Xenobiotica 44:2, pages 109-122.
Read now
Read now
Ana Costa, Bruno Sarmento & Vítor Seabra. (2014) An evaluation of the latest in vitro tools for drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 103-119.
Read now
Read now
Chin Eng Ong, Yan Pan, Joon Wah Mak & Rusli Ismail. (2013)
In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability. Expert Opinion on Drug Metabolism & Toxicology 9:9, pages 1097-1113.
Read now
Read now
Brian G. Lake & Roger J. Price. (2013) Evaluation of the metabolism and hepatotoxicity of xenobiotics utilizing precision-cut slices. Xenobiotica 43:1, pages 41-53.
Read now
Read now
Roslyn S. Thelingwani, Kariema Dhansay, Peter Smith, Kelly Chibale & Collen M. Masimirembwa. (2012) Potent inhibition of CYP1A2 by Frutinone A, an active ingredient of the broad spectrum antimicrobial herbal extract from P. fruticosa. Xenobiotica 42:10, pages 989-1000.
Read now
Read now
Miyoung Yoon, Jerry L. Campbell, Melvin E. Andersen & Harvey J. Clewell. (2012) Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Critical Reviews in Toxicology 42:8, pages 633-652.
Read now
Read now
Anna-Karin Sohlenius-Sternbeck, Christopher Jones, Douglas Ferguson, Brian J. Middleton, Denis Projean, Eva Floby, Johan Bylund & Lovisa Afzelius. (2012) Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes. Xenobiotica 42:9, pages 841-853.
Read now
Read now
Leslie C Bell & Jianling Wang. (2012) Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro–in vivo correlations in early drug discovery. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1131-1155.
Read now
Read now
Hannah M Jones, Maurice Dickins, Kuresh Youdim, James R Gosset, Neil J Attkins, Tanya L Hay, Ian K Gurrell, Y Raj Logan, Peter J Bungay, Barry C Jones & Iain B Gardner. (2012) Application of PBPK modelling in drug discovery and development at Pfizer. Xenobiotica 42:1, pages 94-106.
Read now
Read now
Kyeong-Ryoon Lee, Yoon-Jee Chae & Tae-Sung Koo. (2011) Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats. Xenobiotica 41:12, pages 1100-1107.
Read now
Read now
A.-K. Sohlenius-Sternbeck, L. Afzelius, P. Prusis, J. Neelissen, J. Hoogstraate, J. Johansson, E. Floby, A. Bengtsson, O. Gissberg, J. Sternbeck & C. Petersson. (2010) Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds. Xenobiotica 40:9, pages 637-649.
Read now
Read now
Thierry Lavé, Kathryn Chapman, Paul Goldsmith & Malcolm Rowland. (2009) Human clearance prediction: shifting the paradigm. Expert Opinion on Drug Metabolism & Toxicology 5:9, pages 1039-1048.
Read now
Read now
R. Smith, R. D. O. Jones, P. G. Ballard & H. H. Griffiths. (2008) Determination of microsome and hepatocyte scaling factors for / extrapolation in the rat and dog. Xenobiotica 38:11, pages 1386-1398.
Read now
Read now
D. Hallifax, A. Galetin & J. B. Houston. (2008) Prediction of metabolic clearance using fresh human hepatocytes: Comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines. Xenobiotica 38:4, pages 353-367.
Read now
Read now
Stefan S De Buck & Claire E Mackie. (2007) Physiologically based approaches towards the prediction of pharmacokinetics: in vitro–in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 865-878.
Read now
Read now
John Nichols, Susan Erhardt, Scott Dyer, Margaret James, Margo Moore, Kathleen Plotzke, Helmut Segner, Irvin Schultz, Karluss Thomas, Luba Vasiluk & Annie Weisbrod. (2007) Use of In Vitro Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Bioaccumulation Assessments for Fish. Human and Ecological Risk Assessment: An International Journal 13:6, pages 1164-1191.
Read now
Read now
T. Lavé, N. Parrott, H. P. Grimm, A. Fleury & M. Reddy. (2007) Challenges and opportunities with modelling and simulation in drug discovery and drug development. Xenobiotica 37:10-11, pages 1295-1310.
Read now
Read now
D. Projean, E. Lessard, M. P. Ducharme & J. Ducharme. (2007) Use of Freund's Complete Adjuvant (FCA) in inflammatory pain models: Consequences on the metabolism and pharmacokinetics of the non-peptidic delta receptor agonist SNC80 in the rat. Xenobiotica 37:8, pages 870-883.
Read now
Read now
G. I. Somers, M. K. Bayliss & J. B. Houston. (2007) The metabolism of the 5HT3 antagonists, ondansetron, alosetron and GR87442 II: Investigation into the in vitro methods used to predict the in vivo hepatic clearance of ondansetron, alosetron and GR87442 in the rat, dog and human. Xenobiotica 37:8, pages 855-869.
Read now
Read now
Nicola J. Hewitt, María José Gómez Lechón, J. Brian Houston, David Hallifax, Hayley S. Brown, Patrick Maurel, J. Gerald Kenna, Lena Gustavsson, Christina Lohmann, Christian Skonberg, Andre Guillouzo, Gregor Tuschl, Albert P. Li, Edward LeCluyse, Geny M. M. Groothuis & Jan G. Hengstler. (2007) Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. Drug Metabolism Reviews 39:1, pages 159-234.
Read now
Read now
M. R. Shiran, N. J. Proctor, E. M. Howgate, K. Rowland-Yeo, G. T. Tucker & A. Rostami-Hodjegan. (2006) Prediction of metabolic drug clearance in humans: extrapolation allometric scaling. Xenobiotica 36:7, pages 567-580.
Read now
Read now
E. M. Howgate, K. Rowland Yeo, N. J. Proctor, G. T. Tucker & A. Rostami-Hodjegan. (2006) Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability. Xenobiotica 36:6, pages 473-497.
Read now
Read now
V. P. Hosagrahara, V. P. Hosagrahara, G. Chandrasena, V. P. Hosagrahara, G. Chandrasena, S. Y. Chang, B. Koplowitz, N. Hariharan, P. T. W. Cheng & W. Griffith Humphreys. (2006) Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) α and γ activator, in mice, rats, dogs, and monkeys. Xenobiotica 36:12, pages 1227-1238.
Read now
Read now
H. M. Jones, G. Nicholls & J. B. Houston. (2005) Impact of end-product inhibition on the determination of in vitro metabolic clearance. Xenobiotica 35:5, pages 439-454.
Read now
Read now
T. Yamamoto, N. Hagima, M. Nakamura, Y. Kohno, K. Nagata & Y. Yamazoe. (2004) Prediction of differences in in vivo oral clearance of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100) between extensive and poor metabolizers from in vitro metabolic data in human liver microsomes lacking CYP2D6 activity and recombinant CYPs. Xenobiotica 34:7, pages 687-703.
Read now
Read now
R. De Kanter, M. Monshouwer, A. L. Draaisma, M. H. De Jager, I. A. M. De Graaf, J. H. Proost, D. K. F. Meijer & G. M. M. Groothuis. (2004) Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon. Xenobiotica 34:3, pages 229-241.
Read now
Read now
N. J. Proctor, G. T. Tucker & A. Rostami-Hodjegan. (2004) Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors. Xenobiotica 34:2, pages 151-178.
Read now
Read now
Timothy S. Tracy & Matthew A. Hummel. (2004) Modeling Kinetic Data from In Vitro Drug Metabolism Enzyme Experiments. Drug Metabolism Reviews 36:2, pages 231-242.
Read now
Read now
J. Brian Houston & Aleksandra Galetin. (2003) Progress Towards Prediction of Human Pharmacokinetic Parameters from In Vitro Technologies. Drug Metabolism Reviews 35:4, pages 393-415.
Read now
Read now
A. B. Renwick, S. E. Ball, J. M. Tredger, R. J. Price, D. G. Walters, J. Kao, J. A. Scatina & B. G. Lake. (2002) Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices. Xenobiotica 32:10, pages 849-862.
Read now
Read now
R. De Kanter, M. H. De Jager, A. L. Draaisma, J. U. Jurva, P. Olinga, D. K. F. Meijer & G. M. M. Groothuis. (2002) Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices. Xenobiotica 32:5, pages 349-362.
Read now
Read now
S. E. Clarke & P. Jeffrey. (2001) Utility of metabolic stability screening: comparison of in vitro and in vivo clearance. Xenobiotica 31:8-9, pages 591-598.
Read now
Read now
O. Pelkonen, P. Myllynen, P. Taavitsainen, A. R. Boobis, P. Watts, B. G. Lake, R. J. Price, A. B. Renwick, M.-J. Gómez-Lechón, J. V. Castell, M. Ingelman-Sundberg, M. Hidestrand, A. Guillouzo, L. Corcos, P. S. Goldfarb & D. F. V. Lewis. (2001) Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems. Xenobiotica 31:6, pages 321-343.
Read now
Read now
P. D. Worboys & D. J. Carlile. (2001) Implications and consequences of enzyme induction on preclinical and clinical drug development. Xenobiotica 31:8-9, pages 539-556.
Read now
Read now
R. A. H. J. Gilissen, L. Ferrari, R. J. Barnaby & M. Kajbaf. (2000) Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: in vitro-in vivo correlations. Xenobiotica 30:9, pages 843-856.
Read now
Read now
Articles from other publishers (192)
Siyun Yang & Supratik Kar. (2023) Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artificial Intelligence Chemistry 1:2, pages 100011.
Crossref
Crossref
Nenad Manevski, Kenichi Umehara & Neil Parrott. (2023)
Drug Design and Success of Prospective Mouse In Vitro–In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
p
) from Hepatocyte Intrinsic Clearance (CL
int
)
. Molecular Pharmaceutics 20:7, pages 3438-3459.
Crossref
Crossref
Tashinga E. Bapiro, Scott Martin, Stephen D. Wilkinson, Alexandra L. Orton, Niresh Hariparsad, Stephanie Harlfinger & Dermot F. McGinnity. (2023) The Disconnect in Intrinsic Clearance Determined in Human Hepatocytes and Liver Microsomes Results from Divergent Cytochrome P450 Activities. Drug Metabolism and Disposition 51:7, pages 892-901.
Crossref
Crossref
Xiaonan Li & William J. Jusko. (2022) Assessing Liver-to-Plasma Partition Coefficients and In Silico Calculation Methods: When Does the Hepatic Model Matter in PBPK?. Drug Metabolism and Disposition 50:12, pages 1501-1512.
Crossref
Crossref
Deepika Deepika, Saurav Kumar, Natalia Bravo, Roser Esplugas, Marco Capodiferro, Raju Prasad Sharma, Marta Schuhmacher, Joan O. Grimalt, Jordi Blanco & Vikas Kumar. (2022) Chlorpyrifos, permethrin and cyfluthrin effect on cell survival, permeability, and tight junction in an in-vitro model of the human blood-brain barrier (BBB). NeuroToxicology 93, pages 152-162.
Crossref
Crossref
Wing Y. Tuet, Samuel A. Pierce, Matthieu Conroy, Justin N. Vignola, Justin Tressler, Robert C. diTargiani, Bryan J. McCranor & Benjamin Wong. (2022)
Metabolic clearance of select opioids and opioid antagonists using hepatic spheroids and recombinant cytochrome
P450
enzymes
. Pharmacology Research & Perspectives 10:5.
Crossref
Crossref
Adam S. Darwich, Oliver J. Hatley, Andrés Olivares‐Morales, Farzaneh Salem, Alison Margolskee & Amin Rostami‐Hodjegan. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations
65
86
.
Sophia Krause & Kai-Uwe Goss. (2021) Relevance of desorption kinetics and permeability for in vitro-based predictions of hepatic clearance in fish. Aquatic Toxicology 235, pages 105825.
Crossref
Crossref
Yoo-Kyung Song, Yun-Hwan Seol, Min Ju Kim, Jong-Woo Jeong, Hae-In Choi, Seung-Won Lee, Yoon-Jee Chae, Sunjoo Ahn, Young-Dae Gong, Kyeong-Ryoon Lee & Tae-Sung Koo. (2021) Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats. Pharmaceutics 13:3, pages 373.
Crossref
Crossref
You Gao, Chunmiao Yang, Lingchao Wang, Yanan Xiang, Wenpeng Zhang, Yunfeng Li & Xiaomei Zhuang. (2020) Comparable Intestinal and Hepatic First-Pass Effect of YL-IPA08 on the Bioavailability and Effective Brain Exposure, a Rapid Anti-PTSD and Anti-Depression Compound. Frontiers in Pharmacology 11.
Crossref
Crossref
Xingye Chen, Wuchen Xie, Yan Yang, Yi Hua, GuoMeng Xing, Li Liang, Chenglong Deng, Yuchen Wang, Yuanrong Fan, Haichun Liu, Tao Lu, Yadong Chen & Yanmin Zhang. (2020) Discovery of Dual FGFR4 and EGFR Inhibitors by Machine Learning and Biological Evaluation. Journal of Chemical Information and Modeling 60:10, pages 4640-4652.
Crossref
Crossref
Leslie Z. Benet & Jasleen K. Sodhi. (2020) Investigating the Theoretical Basis for In Vitro–In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways. The AAPS Journal 22:5.
Crossref
Crossref
Alexander M. Horspool, Ting Wang, Young-Sun Scaringella, Mitchell E. Taub & Tom S. Chan. (2020) Human Liver Microsomes Immobilized on Magnetizable Beads: A Novel Approach to Study In Vitro Drug Metabolism. Drug Metabolism and Disposition 48:8, pages 645-654.
Crossref
Crossref
Nyasha Nicole Kapungu, Xueqing Li, Charles Nhachi, Collen Masimirembwa & Roslyn Stella Thelingwani. (2020) In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel. Pharmacology Research & Perspectives 8:4.
Crossref
Crossref
Ravindra Varma Alluri & Manthena V.S. Varma. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
609
631
.
Miyoung Yoon, Gina Song, Harvey Clewell & Bas Blaauboer. 2019. Big Data in Predictive Toxicology. Big Data in Predictive Toxicology
331
358
.
Christine M. Bowman & Leslie Z. Benet. (2019) In Vitro–In Vivo Inaccuracy: The CYP3A4 Anomaly. Drug Metabolism and Disposition 47:12, pages 1368-1371.
Crossref
Crossref
Yuchen Wang, Haichun Liu, Yuanrong Fan, Xingye Chen, Yan Yang, Lu Zhu, Junnan Zhao, Yadong Chen & Yanmin Zhang. (2019) In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy. Journal of Chemical Information and Modeling 59:9, pages 3968-3980.
Crossref
Crossref
Ying Zhu, Qiong Shi, Qi Peng, Yue Gao, Ting Yang, Yu Cheng, Hao Wang, Yetao Luo, Ailong Huang, Tong‑Chuan He & Jiaming Fan. (2019) A simplified 3D liver microsphere tissue culture model for hepatic cell signaling and drug-induced hepatotoxicity studies. International Journal of Molecular Medicine.
Crossref
Crossref
Philip Gardiner, Rhona J. Cox & Ken Grime. (2019) Plasma Protein Binding as an Optimizable Parameter for Acidic Drugs. Drug Metabolism and Disposition 47:8, pages 865-873.
Crossref
Crossref
Christine M. Bowman & Leslie Z. Benet. (2019) Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties. Pharmaceutical Research 36:8.
Crossref
Crossref
Christine M. Bowman & Leslie Z. Benet. (2019) In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction. Journal of Pharmaceutical Sciences 108:7, pages 2500-2504.
Crossref
Crossref
Philippe B. Pierrillas, Emilie Henin, Kathryn Ball, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom & Michel Tod. (2019) Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy. Drug Metabolism and Disposition 47:6, pages 648-656.
Crossref
Crossref
Gregory S. Honda, Robert G. Pearce, Ly L. Pham, R. W. Setzer, Barbara A. Wetmore, Nisha S. Sipes, Jon Gilbert, Briana Franz, Russell S. Thomas & John F. Wambaugh. (2019) Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions. PLOS ONE 14:5, pages e0217564.
Crossref
Crossref
John W. NicholsMelanie A. LaddPatrick N. Fitzsimmons. (2018) Measurement of Kinetic Parameters for Biotransformation of Polycyclic Aromatic Hydrocarbons by Trout Liver S9 Fractions: Implications for Bioaccumulation Assessment. Applied In Vitro Toxicology 4:4, pages 365-378.
Crossref
Crossref
Sophia Krause & Kai-Uwe Goss. (2018)
In Vitro
–
in Vivo
Extrapolation of Hepatic Metabolism for Different Scenarios - a Toolbox
. Chemical Research in Toxicology 31:11, pages 1195-1202.
Crossref
Crossref
Jonathan A. Kyffin, Parveen Sharma, Joseph Leedale, Helen E. Colley, Craig Murdoch, Pratibha Mistry & Steven D. Webb. (2018) Impact of cell types and culture methods on the functionality of in vitro liver systems – A review of cell systems for hepatotoxicity assessment. Toxicology in Vitro 48, pages 262-275.
Crossref
Crossref
Pankaj R. Daga, Michael B. Bolger, Ian S. Haworth, Robert D. Clark & Eric J. Martin. (2018) Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 1. Evaluation and Adaptation of GastroPlus To Predict Bioavailability of Medchem Series. Molecular Pharmaceutics 15:3, pages 821-830.
Crossref
Crossref
Mengying Zhang, Bennard van Ravenzwaay, Eric Fabian, Ivonne M. C. M. Rietjens & Jochem Louisse. (2017) Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data. Archives of Toxicology 92:3, pages 1075-1088.
Crossref
Crossref
Karol Jaroch, Alina Jaroch & Barbara Bojko. (2018) Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment. Journal of Pharmaceutical and Biomedical Analysis 147, pages 297-312.
Crossref
Crossref
Kannan Krishnan. 2018. Handbook of Developmental Neurotoxicology. Handbook of Developmental Neurotoxicology
539
557
.
F. L. Wood, J. B. Houston & D. Hallifax. (2017) Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology. Drug Metabolism and Disposition 45:11, pages 1178-1188.
Crossref
Crossref
Ali Kadar, Georges de Sousa, Ludovic Peyre, Henri Wortham, Pierre Doumenq & Roger Rahmani. (2017) Evidence of in vitro metabolic interaction effects of a chlorfenvinphos, ethion and linuron mixture on human hepatic detoxification rates. Chemosphere 181, pages 666-674.
Crossref
Crossref
Ken Korzekwa & Swati Nagar. (2016) Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning. Pharmaceutical Research 34:3, pages 544-551.
Crossref
Crossref
Toru Takenaka, Kanako Kazuki, Naomoto Harada, Jiro Kuze, Masato Chiba, Takahiro Iwao, Tamihide Matsunaga, Satoshi Abe, Mitsuo Oshimura & Yasuhiro Kazuki. (2017) Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates. Drug Metabolism and Pharmacokinetics 32:1, pages 61-68.
Crossref
Crossref
T.H. Grasela, V. Lukacova, D.N. Morris, R.D. Clark, K.A. Andrews & M.B. Bolger. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
51
82
.
Yi Chen, Joop L. M. Hermens, Michiel T. O. Jonker, Jon A. Arnot, James M. Armitage, Trevor Brown, John W. Nichols, Kellie A. Fay & Steven T. J. Droge. (2016) Which Molecular Features Affect the Intrinsic Hepatic Clearance Rate of Ionizable Organic Chemicals in Fish?. Environmental Science & Technology 50:23, pages 12722-12731.
Crossref
Crossref
Amrita Saxena, Guru R. Valicherla, Girish K. Jain, Rabi S. Bhatta, Anil K. Saxena & Jiaur R. Gayen. (2016)
Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and
in vitro-in vivo
extrapolation
. Biopharmaceutics & Drug Disposition 37:4, pages 185-199.
Crossref
Crossref
Tom De Bruyn, Patrick F. Augustijns & Pieter P. Annaert. (2016) Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat. Journal of Pharmaceutical Sciences 105:2, pages 846-853.
Crossref
Crossref
Tae-Heon Kim, Jong-Woo Jeong, Ji-Hye Song, Kyeong-Ryoon Lee, Sunjoo Ahn, Sung-Hoon Ahn, Sungsub Kim & Tae-Sung Koo. (2015) Pharmacokinetics of enzalutamide, an anti-prostate cancer drug, in rats. Archives of Pharmacal Research 38:11, pages 2076-2082.
Crossref
Crossref
Mehdi Boroujerdi. 2015. Pharmacokinetics and Toxicokinetics. Pharmacokinetics and Toxicokinetics
151
190
.
Xin Hua, Xiao Peng, Shengnan Tan, Chunying Li, Wei Wang, Meng Luo, Yujie Fu, Yuangang Zu & Hugh Smyth. (2014) In Vitro Oxidative Metabolism of Cajaninstilbene Acid by Human Liver Microsomes and Hepatocytes: Involvement of Cytochrome P450 Reaction Phenotyping, Inhibition, and Induction Studies. Journal of Agricultural and Food Chemistry 62:43, pages 10604-10614.
Crossref
Crossref
Jiyue Zheng, Zhaohui Yang, Xuan Li, Linlang Li, Haikuo Ma, Meiyu Wang, Hongjian Zhang, Xuechu Zhen & Xiaohu Zhang. (2014)
Optimization of 6-Heterocyclic-2-(1
H
-pyrazol-1-yl)-
N
-(pyridin-2-yl)pyrimidin-4-amine as Potent Adenosine A
2A
Receptor Antagonists for the Treatment of Parkinson’s Disease
. ACS Chemical Neuroscience 5:8, pages 674-682.
Crossref
Crossref
Tycho Heimbach, Rakesh Gollen & Handan He. 2014. Predictive ADMET. Predictive ADMET
319
352
.
Diane Ramsden, Donald J. Tweedie, Roger St. George, Lin-Zhi Chen & Yongmei Li. (2014) Generating an In Vitro–In Vivo Correlation for Metabolism and Liver Enrichment of a Hepatitis C Virus Drug, Faldaprevir, Using a Rat Hepatocyte Model (HepatoPac). Drug Metabolism and Disposition 42:3, pages 407-414.
Crossref
Crossref
Diane Ramsden, Donald J. Tweedie, Tom S. Chan, Mitchell E. Taub & Yongmei Li. (2014) Bridging In Vitro and In Vivo Metabolism and Transport of Faldaprevir in Human Using a Novel Cocultured Human Hepatocyte System, HepatoPac. Drug Metabolism and Disposition 42:3, pages 394-406.
Crossref
Crossref
John W. Nichols, Alex D. Hoffman, Thomas L. ter Laak & Patrick N. Fitzsimmons. (2013) Hepatic Clearance of 6 Polycyclic Aromatic Hydrocarbons by Isolated Perfused Trout Livers: Prediction From In Vitro Clearance by Liver S9 Fractions. Toxicological Sciences 136:2, pages 359-372.
Crossref
Crossref
Chris De Savi, David Waterson, Andrew Pape, Scott Lamont, Elma Hadley, Mark Mills, Ken M. Page, Jonathan Bowyer & Rose A. Maciewicz. (2013) Hydantoin based inhibitors of MMP13—Discovery of AZD6605. Bioorganic & Medicinal Chemistry Letters 23:16, pages 4705-4712.
Crossref
Crossref
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
Yuan Lu, Jinbo Yang, Haiyan Zhang & Jin Yang. (2013) Prediction of Warfarin Maintenance Dose in Han Chinese Patients Using a Mechanistic Model Based on Genetic and Non-Genetic Factors. Clinical Pharmacokinetics 52:7, pages 567-581.
Crossref
Crossref
Jian YinHongxia QiuJing DaiYanhua LuRong ZhaoLi ChenQin Meng. (2013) Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes. Canadian Journal of Physiology and Pharmacology 91:2, pages 178-186.
Crossref
Crossref
John Jack, John Wambaugh & Imran Shah. 2013. Computational Toxicology. Computational Toxicology
375
397
.
J. Brian Houston, Karen Rowland-Yeo & Ugo Zanelli. (2012) Evaluation of the novel in vitro systems for hepatic drug clearance and assessment of their predictive utility. Toxicology in Vitro 26:8, pages 1265-1271.
Crossref
Crossref
Li Di, Christopher Keefer, Dennis O. Scott, Timothy J. Strelevitz, George Chang, Yi-An Bi, Yurong Lai, Jonathon Duckworth, Katherine Fenner, Matthew D. Troutman & R. Scott Obach. (2012) Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. European Journal of Medicinal Chemistry 57, pages 441-448.
Crossref
Crossref
Cornelia M. Smith, Christina K. Nolan, Manda A. Edwards, Jean B. Hatfield, Todd W. Stewart, Stephen S. Ferguson, Edward L. Lecluyse & Jasminder Sahi. (2012) A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes. Journal of Pharmaceutical Sciences 101:10, pages 3989-4002.
Crossref
Crossref
Paulo Paixão, Luís F. Gouveia & José A.G. Morais. (2012) Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model. International Journal of Pharmaceutics 429:1-2, pages 84-98.
Crossref
Crossref
Liang Ma, Jeremy Barker, Changchun Zhou, Wei Li, Jing Zhang, Biaoyang Lin, Gregory Foltz, Jenni K?blbeck & Paavo Honkakoski. (2012) Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system. Biomaterials 33:17, pages 4353-4361.
Crossref
Crossref
Jean Matthieu Prot & Eric Leclerc. (2011) The Current Status of Alternatives to Animal Testing and Predictive Toxicology Methods Using Liver Microfluidic Biochips. Annals of Biomedical Engineering 40:6, pages 1228-1243.
Crossref
Crossref
Jialin Mao, Michael A. Mohutsky, John P. Harrelson, Steven A. Wrighton & Stephen D. Hall. (2012) Predictions of Cytochrome P450-Mediated Drug-Drug Interactions Using Cryopreserved Human Hepatocytes: Comparison of Plasma and Protein-Free Media Incubation Conditions. Drug Metabolism and Disposition 40:4, pages 706-716.
Crossref
Crossref
Ya-Ping Tu. (2012) Dissociative protonation and fragmentation: Retro-Friedel?Crafts reactions of heterocyclic drug and metabolite molecules in mass spectrometry. International Journal of Mass Spectrometry 316-318, pages 40-46.
Crossref
Crossref
R. Scott Obach. 2012. Predictive Approaches in Drug Discovery and Development. Predictive Approaches in Drug Discovery and Development
289
306
.
Yuan Chen, Jin Y. Jin, Sophie Mukadam, Vikram Malhi & Jane R. Kenny. (2012) Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies. Biopharmaceutics & Drug Disposition 33:2, pages 85-98.
Crossref
Crossref
Ganesh M. Mugundu, Larry Sallans, Yingying Guo, Elizabeth A. Shaughnessy & Pankaj B. Desai. (2012)
Assessment of the Impact of CYP3A Polymorphisms on the Formation of α-Hydroxytamoxifen and
N
-Desmethyltamoxifen in Human Liver Microsomes
. Drug Metabolism and Disposition 40:2, pages 389-396.
Crossref
Crossref
Peter Ballard & Malcolm Rowland. (2011)
Correction for Nonspecific Binding to Various Components of Ultrafiltration Apparatus and Impact on Estimating In Vivo Rat Clearance for a Congeneric Series of 5-Ethyl, 5-
n
-Alkyl Barbituric Acids
. Drug Metabolism and Disposition 39:12, pages 2165-2168.
Crossref
Crossref
Jiansong Yang. 2011. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development
59
92
.
Ying Qi Ge, Xiao Ping Luo & Qian Ming Mao. (2011) Application of ICA-CMAC in the Prediction of Human Hepatic Clearance. Advanced Materials Research 268-270, pages 1759-1762.
Crossref
Crossref
Chris De Savi, Andrew Pape, Yvonne Sawyer, David Milne, Chris Davies, John G. Cumming, Attilla Ting, Scott Lamont, Peter D. Smith, Jonathon Tart, Ken Page & Peter Moore. (2011) Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3301-3306.
Crossref
Crossref
Vikash K. Sinha, Karin Vaarties, Stefan S. De Buck, Luca. A. Fenu, Marjoleen Nijsen, Ron A.H.J. Gilissen, Wendy Sanderson, Kelly Van Uytsel, Eva Hoeben, Achiel Van Peer, Claire E. Mackie & Johan W. Smit. (2011) Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry. Clinical Pharmacokinetics 50:5, pages 307-318.
Crossref
Crossref
Shinji Yamazaki, Judith Skaptason, David Romero, Sylvia Vekich, Hannah M. Jones, Weiwei Tan, Keith D. Wilner & Tatiana Koudriakova. (2011) Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model. Drug Metabolism and Disposition 39:3, pages 383-393.
Crossref
Crossref
Chris De Savi, Andrew Pape, John G. Cumming, Attilla Ting, Peter D. Smith, Jeremy N. Burrows, Mark Mills, Chris Davies, Scott Lamont, David Milne, Calum Cook, Peter Moore, Yvonne Sawyer & Stefan Gerhardt. (2011) The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters 21:5, pages 1376-1381.
Crossref
Crossref
Hayley S. Brown, Alison J. Wilby, Jane Alder & J. Brian Houston. (2010) Comparative Use of Isolated Hepatocytes and Hepatic Microsomes for Cytochrome P450 Inhibition Studies: Transporter-Enzyme Interplay. Drug Metabolism and Disposition 38:12, pages 2139-2146.
Crossref
Crossref
Christopher S. Mazur, John F. Kenneke, Janet K. Hess-Wilson & John C. Lipscomb. (2010) Differences between Human and Rat Intestinal and Hepatic Bisphenol A Glucuronidation and the Influence of Alamethicin on In Vitro Kinetic Measurements. Drug Metabolism and Disposition 38:12, pages 2232-2238.
Crossref
Crossref
Lena E. Friberg, Marie Sandström & Mats O. Karlsson. (2009) Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model. Investigational New Drugs 28:6, pages 744-753.
Crossref
Crossref
Sami Haddad, Patrick Poulin & Christoph Funk. (2010) Extrapolating In vitro Metabolic Interactions to Isolated Perfused Liver: Predictions of Metabolic Interactions between R-Bufuralol, Bunitrolol, and Debrisoquine. Journal of Pharmaceutical Sciences 99:10, pages 4406-4426.
Crossref
Crossref
Lorrene A. Buckley, Parag Garhyan, Rafael Ponce & Stanley A. Roberts. 2010. Early Drug Development. Early Drug Development
421
463
.
Huadong Sun, Ying-Ying Zeng & K. Sandy Pang. (2010)
Interplay of Phase II Enzymes and Transporters in Futile Cycling: Influence of Multidrug Resistance-Associated Protein 2-Mediated Excretion of Estradiol 17β-d-Glucuronide and Its 3-Sulfate Metabolite on Net Sulfation in Perfused TR
−
and Wistar Rat Liver Preparations
. Drug Metabolism and Disposition 38:5, pages 769-780.
Crossref
Crossref
P Workman, E O Aboagye, F Balkwill, A Balmain, G Bruder, D J Chaplin, J A Double, J Everitt, D A H Farningham, M J Glennie, L R Kelland, V Robinson, I J Stratford, G M Tozer, S Watson, S R Wedge & S A Eccles. (2010) Guidelines for the welfare and use of animals in cancer research. British Journal of Cancer 102:11, pages 1555-1577.
Crossref
Crossref
Shayne Cox GadHarvey J. ClewellIIIIII, Micaela B. Reddy, Thierry Lave & Melvin E. Andersen. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Shayne Cox GadJane R. Kenny, Dermot F. McGinnity, Ken Grime & Robert J. Riley. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Paulo Paixão, Luís F. Gouveia & José A.G. Morais. (2010) Prediction of the in vitro intrinsic clearance determined in suspensions of human hepatocytes by using artificial neural networks. European Journal of Pharmaceutical Sciences 39:5, pages 310-321.
Crossref
Crossref
Urban Fagerholm. (2007) Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance. Journal of Pharmacy and Pharmacology 59:6, pages 803-828.
Crossref
Crossref
Juthamas Sukbuntherng, Gillian Cropp, Alison Hannah, Gregory S Wagner, Laura K Shawver & Lida Antonian. (2001) Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416. Journal of Pharmacy and Pharmacology 53:12, pages 1629-1636.
Crossref
Crossref
Takahide Uchimura, Motohiro Kato, Tomohisa Saito & Haruki Kinoshita. (2010) Prediction of human blood-to-plasma drug concentration ratio. Biopharmaceutics & Drug Disposition, pages n/a-n/a.
Crossref
Crossref
Cristiano Migliorini, Thierry Lave, Neil J. Parrott, Micaela Reddy, Hans Peter Grimm, Robert C. Penland, Antoine Soubret, Gabriel Helmlinger, Anna Georgieva & Klaas P. Zuideveld. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Haiyan Li, Jin Sun, Xiaofan Sui, Zhongtian Yan, Yinghua Sun, Xiaohong Liu, Yongjun Wang & Zhonggui He. (2009) Structure-Based Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes. The AAPS Journal 11:2, pages 364-370.
Crossref
Crossref
Masato Chiba, Yasuyuki Ishii & Yuichi Sugiyama. (2009) Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development. The AAPS Journal 11:2.
Crossref
Crossref
Stefan Balaz. (2009) Modeling Kinetics of Subcellular Disposition of Chemicals. Chemical Reviews 109:5, pages 1793-1899.
Crossref
Crossref
K. Sandy Pang. (2009) Safety testing of metabolites: Expectations and outcomes. Chemico-Biological Interactions 179:1, pages 45-59.
Crossref
Crossref
Hannah M. Jones, Iain B. Gardner & Kenny J. Watson. (2009) Modelling and PBPK Simulation in Drug Discovery. The AAPS Journal 11:1, pages 155-166.
Crossref
Crossref
Erik Sjögren, Hans Lennernäs, Tommy B. Andersson, Johan Gråsjö & Ulf Bredberg. (2009)
The Multiple Depletion Curves Method Provides Accurate Estimates of Intrinsic Clearance (CL
int
), Maximum Velocity of the Metabolic Reaction (
V
max
), and Michaelis Constant (
K
m
): Accuracy and Robustness Evaluated through Experimental Data and Monte Carlo Simulations
. Drug Metabolism and Disposition 37:1, pages 47-58.
Crossref
Crossref
René Kupfer, Leah Swanson, Sylvia Chow, Richard E. Staub, Yan Ling Zhang, Isaac Cohen & Uwe Christians. (2008) Oxidative in Vitro Metabolism of Liquiritigenin, a Bioactive Compound Isolated from the Chinese Herbal Selective Estrogen β-Receptor Agonist MF101. Drug Metabolism and Disposition 36:11, pages 2261-2269.
Crossref
Crossref
A. Guillouzo. (2008) Nouvelles perspectives d’utilisation des hépatocytes humains au cours du développement préclinique des médicaments. Annales Pharmaceutiques Françaises 66:5-6, pages 288-295.
Crossref
Crossref
Chris Logan. 2008. Drug Bioavailability. Drug Bioavailability
161
184
.
Alison J. Parker & J. Brian Houston. (2008) Rate-Limiting Steps in Hepatic Drug Clearance: Comparison of Hepatocellular Uptake and Metabolism with Microsomal Metabolism of Saquinavir, Nelfinavir, and Ritonavir. Drug Metabolism and Disposition 36:7, pages 1375-1384.
Crossref
Crossref
Stuart W. Paine, Alison J. Parker, Philip Gardiner, Peter J. H. Webborn & Robert J. Riley. (2008) Prediction of the Pharmacokinetics of Atorvastatin, Cerivastatin, and Indomethacin Using Kinetic Models Applied to Isolated Rat Hepatocytes. Drug Metabolism and Disposition 36:7, pages 1365-1374.
Crossref
Crossref
John C. Lipscomb & Torka S. Poet. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology & Therapeutics 118:1, pages 82-103.
Crossref
Crossref
Amrita V. Kamath, Jian Wang, Francis Y. Lee & Punit H. Marathe. (2007) Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL. Cancer Chemotherapy and Pharmacology 61:3, pages 365-376.
Crossref
Crossref
Kevin Kleinow, John Nichols, William Hayton, James McKim & Mace Barron. 2008. The Toxicology of Fishes. The Toxicology of Fishes
55
152
.
Christina E. Cowan-Ellsberry, Scott D. Dyer, Susan Erhardt, Mary Jo Bernhard, Amy L. Roe, Martin E. Dowty & Annie V. Weisbrod. (2008) Approach for extrapolating in vitro metabolism data to refine bioconcentration factor estimates. Chemosphere 70:10, pages 1804-1817.
Crossref
Crossref
Punit H. Marathe, Christine Huang & A. David Rodrigues. 2008.
311
328
.
Yanmin Chen, Deping Cheng, Cesar Tio, Natashia Kagan, Stephen Eisennagel, Malini Dasgupta, Bruce Tomczuk, Roger Bone & Norman Huebert. (2008)
Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and
in vitro
drug metabolism
. Biopharmaceutics & Drug Disposition 29:3, pages 127-138.
Crossref
Crossref
Takahide Uchimura, Motohiro Kato, Tatsuhiko Tachibana, Shinichi Arai, Yoshiaki Nabuchi, Kimitoshi Saito & Haruki Kinoshita. (2007) New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibition. Biopharmaceutics & Drug Disposition 29:1, pages 7-16.
Crossref
Crossref
Jane Alcorn, Fawzy A. Elbarbry, Mohammed Z. Allouh & Patrick J. McNamara. (2007) Evaluation of the Assumptions of an Ontogeny Model of Rat Hepatic Cytochrome P450 Activity. Drug Metabolism and Disposition 35:12, pages 2225-2231.
Crossref
Crossref
Klaus Urbahns, Michael Härter, Markus Albers, Delf Schmidt, Beatrix Stelte-Ludwig, Ulf Brüggemeier, Andrea Vaupel, Jörg Keldenich, Klemens Lustig, Hideki Tsujishita & Christoph Gerdes. (2007) Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides. Bioorganic & Medicinal Chemistry Letters 17:22, pages 6151-6154.
Crossref
Crossref
Stefan S. De Buck, Vikash K. Sinha, Luca A. Fenu, Marjoleen J. Nijsen, Claire E. Mackie & Ron A. H. J. Gilissen. (2007) Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs. Drug Metabolism and Disposition 35:10, pages 1766-1780.
Crossref
Crossref
Jennifer B. Dennison, David R. Jones, Jamie L. Renbarger & Stephen D. Hall. (2007) Effect of CYP3A5 Expression on Vincristine Metabolism with Human Liver Microsomes. Journal of Pharmacology and Experimental Therapeutics 321:2, pages 553-563.
Crossref
Crossref
Matthew G. Soars, Dermot F. McGinnity, Ken Grime & Robert J. Riley. (2007) The pivotal role of hepatocytes in drug discovery. Chemico-Biological Interactions 168:1, pages 2-15.
Crossref
Crossref
Lilian G. Yengi, Louis Leung & John Kao. (2007) The Evolving Role of Drug Metabolism in Drug Discovery and Development. Pharmaceutical Research 24:5.
Crossref
Crossref
Stefan S. De Buck, Vikash K. Sinha, Luca A. Fenu, Ron A. Gilissen, Claire E. Mackie & Marjoleen J. Nijsen. (2007) The Prediction of Drug Metabolism, Tissue Distribution, and Bioavailability of 50 Structurally Diverse Compounds in Rat Using Mechanism-Based Absorption, Distribution, and Metabolism Prediction Tools. Drug Metabolism and Disposition 35:4, pages 649-659.
Crossref
Crossref
Amin Rostami-Hodjegan & Geoffrey T. Tucker. (2007) Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nature Reviews Drug Discovery 6:2, pages 140-148.
Crossref
Crossref
T. Laveé, N. Parrott & H. Jones. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
867
884
.
David Hallifax & J. Brian Houston. (2006) Uptake and Intracellular Binding of Lipophilic Amine Drugs by Isolated Rat Hepatocytes and Implications for Prediction of in Vivo Metabolic Clearance. Drug Metabolism and Disposition 34:11, pages 1829-1836.
Crossref
Crossref
Pilar Prieto, Alan W. Baird, Bas J. Blaauboer, Jose Vicente Castell Ripoll, Raffaella Corvi, Wolfgang Dekant, Paul Dietl, Alessandra Gennari, Laura Gribaldo, Julian L. Griffin, Thomas Hartung, Jerry J. Heindel, Peter Hoet, Paul Jennings, Luciana Marocchio, Jens Noraberg, Patricia Pazos, Carl Westmoreland, Armin Wolf, Jayne Wright & Walter Pfaller. (2019)
The Assessment of Repeated Dose Toxicity
In Vitro
: A Proposed Approach
. Alternatives to Laboratory Animals 34:3, pages 315-341.
Crossref
Crossref
John W. Nichols, Irvin R. Schultz & Patrick N. Fitzsimmons. (2006) In vitro–in vivo extrapolation of quantitative hepatic biotransformation data for fish. Aquatic Toxicology 78:1, pages 74-90.
Crossref
Crossref
Sara M. Skaggs, Robert S. Foti & Michael B. Fisher. (2006) A streamlined method to predict hepatic clearance using human liver microsomes in the presence of human plasma. Journal of Pharmacological and Toxicological Methods 53:3, pages 284-290.
Crossref
Crossref
Li Zhang, Ge Lin & Zhong Zuo. (2006) Position preference on glucuronidation of mono-hydroxylflavones in human intestine. Life Sciences 78:24, pages 2772-2780.
Crossref
Crossref
Rakesh Nagilla, Kelly A. Frank, Larry J. Jolivette & Keith W. Ward. (2006) Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance. Journal of Pharmacological and Toxicological Methods 53:2, pages 106-116.
Crossref
Crossref
Nancy Hakooz, Kiyomi Ito, Helen Rawden, Helen Gill, Lynn Lemmers, Alan R. Boobis, Robert J. Edwards, David J. Carlile, Brian G. Lake & J. Brian Houston. (2006) Determination of a Human Hepatic Microsomal Scaling Factor for Predicting in Vivo Drug Clearance. Pharmaceutical Research 23:3, pages 533-539.
Crossref
Crossref
Ruth Hyland, Barry Jones & Han van de Waterbeemd. (2006) Utility of human/human-derived reagents in drug discovery and development: An industrial perspective. Environmental Toxicology and Pharmacology 21:2, pages 179-183.
Crossref
Crossref
Timothy S Tracy. (2006) Atypical Cytochrome P450 Kinetics. Drugs in R & D 7:6, pages 349-363.
Crossref
Crossref
Hannah M Jones, Neil Parrott, Karin Jorga & Thierry Lav??. (2006) A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics. Clinical Pharmacokinetics 45:5, pages 511-542.
Crossref
Crossref
Dhiren R. Thakker. 2006. Optimizing the “Drug-Like” Properties of Leads in Drug Discovery. Optimizing the “Drug-Like” Properties of Leads in Drug Discovery
1
23
.
John G. Cumming, Anne E. Cooper, Ken Grime, Chris J. Logan, Sharon McLaughlin, John Oldfield, John S. Shaw, Howard Tucker, Jon Winter & David Whittaker. (2005) Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters 15:22, pages 5012-5015.
Crossref
Crossref
Robert J. Riley, D. F. McGinnity & R. P. Austin. (2005) A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES. Drug Metabolism and Disposition 33:9, pages 1304-1311.
Crossref
Crossref
Trevor N. Johnson. (2005) Modelling approaches to dose estimation in children. British Journal of Clinical Pharmacology 59:6, pages 663-669.
Crossref
Crossref
Neil Parrott, Hannah Jones, Nicolas Paquereau & Thierry Lave. (2005) Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 96:3, pages 193-199.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen, Jouko Uusitalo, Arja Rautio & Hannu Raunio. (2005) Prediction of Drug Metabolism and Interactions on the Basis of in vitro Investigations. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 96:3, pages 167-175.
Crossref
Crossref
Anita Reddy, Tycho Heimbach, Sascha Freiwald, Danielle Smith, Roger Winters, Steven Michael, Narayanan Surendran & Hongliang Cai. (2005) Validation of a semi-automated human hepatocyte assay for the determination and prediction of intrinsic clearance in discovery. Journal of Pharmaceutical and Biomedical Analysis 37:2, pages 319-326.
Crossref
Crossref
Sarah J. Griffin & J. Brian Houston. (2005) PREDICTION OF IN VITRO INTRINSIC CLEARANCE FROM HEPATOCYTES: COMPARISON OF SUSPENSIONS AND MONOLAYER CULTURES. Drug Metabolism and Disposition 33:1, pages 115-120.
Crossref
Crossref
Kiyomi Ito & J. Brian Houston. (2005) Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches. Pharmaceutical Research 22:1, pages 103-112.
Crossref
Crossref
Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. GraceJr.Jr., Mingxin Qian, Kan He, Krishnaswamy Yeleswaram & David D. Christ. (2004)
THE CHIMPANZEE (
PAN TROGLODYTES
) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
. Drug Metabolism and Disposition 32:12, pages 1359-1369.
Crossref
Crossref
Robert J. Riley & Ken Grime. (2004) Metabolic screening in vitro: metabolic stability, CYP inhibition and induction. Drug Discovery Today: Technologies 1:4, pages 365-372.
Crossref
Crossref
Dermot F. McGinnity, Matthew G. Soars, Richard A. Urbanowicz & Robert J. Riley. (2004) EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE. Drug Metabolism and Disposition 32:11, pages 1247-1253.
Crossref
Crossref
Nadège Blanchard, Lysiane Richert, Brigitte Notter, Frederic Delobel, Pascale David, Philippe Coassolo & Thierry Lavé. (2004) Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes. European Journal of Pharmaceutical Sciences 23:2, pages 189-199.
Crossref
Crossref
Hannah M. Jones & J. Brian Houston. (2004) SUBSTRATE DEPLETION APPROACH FOR DETERMINING IN VITRO METABOLIC CLEARANCE: TIME DEPENDENCIES IN HEPATOCYTE AND MICROSOMAL INCUBATIONS. Drug Metabolism and Disposition 32:9, pages 973-982.
Crossref
Crossref
Andrew M Davis & Robert J Riley. (2004) Predictive ADMET studies, the challenges and the opportunities. Current Opinion in Chemical Biology 8:4, pages 378-386.
Crossref
Crossref
Sarah J. Griffin & J. Brian Houston. (2004) COMPARISON OF FRESH AND CRYOPRESERVED RAT HEPATOCYTE SUSPENSIONS FOR THE PREDICTION OF IN VITRO INTRINSIC CLEARANCE. Drug Metabolism and Disposition 32:5, pages 552-558.
Crossref
Crossref
Roger J. Price, Anthony B. Renwick, David G. Walters, Philip J. Young & Brian G. Lake. (2004) Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicology in Vitro 18:2, pages 179-185.
Crossref
Crossref
Graham Somers, Peter Mutch & Amanda Woodrooffe. 2004. A Handbook of Bioanalysis and Drug Metabolism. A Handbook of Bioanalysis and Drug Metabolism.
John H. Ansede & Dhiren R. Thakker. (2004) High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolism. Journal of Pharmaceutical Sciences 93:2, pages 239-255.
Crossref
Crossref
Thierry Lavé, Olivier Luttringer, Patrick Poulin & Neil Parrott. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
133
175
.
Lawrence X. Yu, Christopher D. Ellison & Ajaz S. Hussain. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
53
74
.
John C. Lipscomb, Linda K. Teuschler, Jeff Swartout, Doug Popken, Tony Cox & Gregory L. Kedderis. (2003) The Impact of Cytochrome P450 2E1‐Dependent Metabolic Variance on a Risk‐Relevant Pharmacokinetic Outcome in Humans. Risk Analysis 23:6, pages 1221-1238.
Crossref
Crossref
Masato Chiba, Yuichi Sugiyama, Yasuyuki Ishii, Hiroyuki Takahashi & Yoshihiro Shibata. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
453
481
.
Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen & Olavi Pelkonen. (2003) COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS. Drug Metabolism and Disposition 31:9, pages 1093-1102.
Crossref
Crossref
John M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly & William F. Trager. (2003)
K
I
IV, AN IN VIVO PARAMETER FOR PREDICTING THE
MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME
INHIBITION
. Drug Metabolism and Disposition 31:8, pages 1043-1048.
Crossref
Crossref
Gary W. Caldwell, Zhengyin Yan, John A. Masucci, William Hageman, Gregory Leo & David M. Ritchie. (2012) Applied Pharmacokinetics in Drug Development. Pharmaceutical Development and Regulation 1:2, pages 117-132.
Crossref
Crossref
Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama & Yuichi Sugiyama. (2003) Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro. Drug Metabolism and Disposition 31:5, pages 580-588.
Crossref
Crossref
Frank-Peter Theil, Theodor W Guentert, Sami Haddad & Patrick Poulin. (2003) Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection. Toxicology Letters 138:1-2, pages 29-49.
Crossref
Crossref
Jaeick Lee, Junghyun Son, Hun Yeoung Koh, Ae Nim Pae & Dong-Hyun Kim. (2003) Rapid analysis of metabolic stability of dopamine receptor antagonists and detection of their metabolites by liquid chromatography/tandem mass spectrometry. Analytical Biochemistry 313:2, pages 292-300.
Crossref
Crossref
Ivan Nestorov. (2003) Whole Body Pharmacokinetic Models. Clinical Pharmacokinetics 42:10, pages 883-908.
Crossref
Crossref
Collen M Masimirembwa, Ulf Bredberg & Tommy B Andersson. (2003) Metabolic Stability for Drug Discovery and Development. Clinical Pharmacokinetics 42:6, pages 515-528.
Crossref
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
Crossref
Han van de Waterbeemd & Barry C Jones. 2003.
1
59
.
Bas J. Blaauboer. (2002)
The Necessity of Biokinetic Information in the Interpretation of
In Vitro
Toxicity Data
. Alternatives to Laboratory Animals 30:2_suppl, pages 85-91.
Crossref
Crossref
Sanjeev Kumar, Koppara Samuel, Ramaswamy Subramanian, Matthew P. Braun, Ralph A. Stearns, Shuet-Hing Lee Chiu, David C. Evans & Thomas A. Baillie. (2002) Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl Glucuronide. Journal of Pharmacology and Experimental Therapeutics 303:3, pages 969-978.
Crossref
Crossref
Yau Yi Lau, Elpida Sapidou, Xiaoming Cui, Ronald E. White & K.-C. Cheng. (2002) Development of a Novel in Vitro Model to Predict Hepatic Clearance Using Fresh, Cryopreserved, and Sandwich-Cultured Hepatocytes. Drug Metabolism and Disposition 30:12, pages 1446-1454.
Crossref
Crossref
Chyung S. Cook, Loren M. Berry, David H. Kim, Earl G. Burton, Jeremy D. Hribar & Liming Zhang. (2002) Involvement of CYP3A in the Metabolism of Eplerenone in Humans and Dogs: Differential Metabolism by CYP3A4 and CYP3A5. Drug Metabolism and Disposition 30:12, pages 1344-1351.
Crossref
Crossref
Displaying 200 of 234 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list